EUVIMEDEUVIMED entdecken
Crossref

Dual-Antiplatelet Therapy After Coronary Artery Bypass Grafting: A Survey of UK Cardiac Surgeons

Maria Comanici, Shahzad G Raja

Journal of Cardiothoracic and Vascular Anesthesia · 2023-12 · 37 (12) · 2517-2523

DOI: 10.1053/j.jvca.2023.08.146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiothoracic and Vascular Anesthesia, 2023-12. Verfasst von Maria Comanici und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Harefield Hospital, London, United Kingdom. Electronic address: maria.comanici9@gmail.com. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Surgeons. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Antiplatelet therapy after coronary artery bypass grafting (CABG) is important in postoperative medical management. Although cardiac surgeons are well-versed in the guidelines regarding discontinuation of dual-antiplatelet therapy (DAPT; aspirin and a P2Y12 antagonist) before CABG to minimize bleeding risk, there is considerable variability in DAPT dosing after CABG. The objective of this study was to explore the current trends in DAPT after CABG in the UK to improve understanding of the existing practice. DESIGN: This study used an online survey with 9 questions about the use of DAPT after CABG. An invitation to participate was sent to all adult cardiac surgeons currently in practice in the UK and the Republic of Ireland. SETTING: The study was conducted in the UK and the Republic of Ireland. PARTICIPANTS: Participants in this study were adult cardiac surgeons currently in practice in the UK and the Republic of Ireland. INTERVENTIONS: There were no interventions in this study. MEASUREMENTS AND MAIN RESULTS: Responses were received from across the UK (85.4% UK; 4% each from Scotland and Northern Ireland, 1.3% from Wales) and 5.3% from the Republic of Ireland. Fifty-seven percent of the respondents performed between 50 and 100 CABGs per year. Ninety-one percent of the respondents prescribe DAPT postoperatively, but the choice of which patients receive it varied. Most responding surgeons used DAPT for selective patient cohorts, such as those with acute coronary syndrome (51%), diffuse coronary artery disease (42%), perioperative myocardial infarction (36%), coronary endarterectomy (31%), or when bypassing a stented coronary artery (23%). Thirty-eight percent of the respondents began all their patients with CABGs on DAPT. The most preferred P2Y12 antagonist was clopidogrel, used by 75% of respondents and introduced on day 1 after surgical revascularization (71%). The routine duration for DAPT is 12 months, which 78% of the respondents preferred. The main reason for not starting DAPT in those surveyed was the bleeding risk associated with DAPT (72%). CONCLUSIONS: The survey uncovered variation in the use of DAPT after CABG. However, DAPT remains the preferred strategy after CABG in the UK. The study highlighted the need to develop standardized protocols for DAPT after CABG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsSurgeonsAdultHumansDrug Therapy, CombinationCoronary Artery BypassUnited KingdomTreatment Outcome

Stichwörter der Autor:innen

P2Y12 antagonistcoronary artery bypass graftingdual antiplatelet therapysurvey

Substanzen

Platelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Cardiac Surgery, Harefield Hospital, London, United Kingdom. Electronic address: maria.comanici9@gmail.com.
  • Department of Cardiac Surgery, Harefield Hospital, London, United Kingdom.

Zitieren

APA

Comanici, M., & Raja, S. G. (2023). Dual-Antiplatelet Therapy After Coronary Artery Bypass Grafting: A Survey of UK Cardiac Surgeons. Journal of Cardiothoracic and Vascular Anesthesia, 37(12), 2517-2523. https://doi.org/10.1053/j.jvca.2023.08.146

Vancouver

Comanici M, Raja SG. Dual-Antiplatelet Therapy After Coronary Artery Bypass Grafting: A Survey of UK Cardiac Surgeons. Journal of Cardiothoracic and Vascular Anesthesia. 2023;37(12):2517-2523. doi:10.1053/j.jvca.2023.08.146

BibTeX
@article{Comanici2023,
  author = {Comanici, Maria and Raja, Shahzad G},
  title = {Dual-Antiplatelet Therapy After Coronary Artery Bypass Grafting: A Survey of UK Cardiac Surgeons},
  journal = {Journal of Cardiothoracic and Vascular Anesthesia},
  year = {2023},
  volume = {37},
  number = {12},
  pages = {2517--2523},
  doi = {10.1053/j.jvca.2023.08.146}
}
Kostenlos starten →